semaglutide news oct 26 2025 Use of semaglutide linked to doubled risk of neovascular macular degeneration

Americans turn to risky unregulated sellers for GLP-1 weight-loss drugs

26.97

★★★★☆4.8 (126)

Medicare negotiated lower prices for 15 drugs, including 71% off Ozempic and Wegovy : Shots

27.57

★★★★★4.9 (98)

FDA has approved a new oral form of semaglutide for long-term weight reduction in adults with obesity or overweight. The new oral tablet is also indicated for reducing the risk of major

20.22

★★★★★5.0 (157)

FDA has approved a new oral form of semaglutide for long-term weight reduction in adults with obesity or overweight. The new oral tablet is also indicated for reducing the risk of major

21.05

★★★★★4.7 (84)

There's a surprising new benefit from taking GLP-1 weight loss drugs—using the medication is associated with lower breast cancer incidents, according to a published study. Latest Medical Watch Daily Digest: ( https://wgntv.com/news/medical-watch/glp-1

25.60

★★★★★4.9 (203)

Weight-loss drugs such as Ozempic were in the headlines a lot in 2025 – and patent protections for these drugs expire in some countries in 2026. In this edition of #PeriodicGraphics in @

28.08

★★★★★5.0 (176)

Best Semaglutide Options for 2026: New Oral Wegovy Pill Approved by FDA as Patients Compare Injectable and Compounded Access Pathways

28.45

★★★★★4.8 (132)